Saw Palmetto En Banc Appeals Court Re-Hearing Requested
This article was originally published in The Tan Sheet
Executive Summary
A group of supplement marketers seeking approval of a health claim linking saw palmetto to treatment of benign prostatic hyperplasia have filed a petition for an en banc rehearing with the U.S. Court of Appeals
You may also be interested in...
House Bills Aim To Loosen Health Claims Regs, Fully Fund DSHEA
A new House bill is designed to add flexibility to FDA's health claims oversight, allowing supplement manufacturers to make scientifically accurate disease claims
House Bills Aim To Loosen Health Claims Regs, Fully Fund DSHEA
A new House bill is designed to add flexibility to FDA's health claims oversight, allowing supplement manufacturers to make scientifically accurate disease claims
House Bills Aim To Loosen Health Claims Regs, Fully Fund DSHEA
A new House bill is designed to add flexibility to FDA's health claims oversight, allowing supplement manufacturers to make scientifically accurate disease claims